Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You are scheduled to have surgery to fully remove a lung cancer tumor, and after surgery the tissue is confirmed to be primary lung cancer (cancer that started in the lung)
- During surgery, doctors are able to collect a sample of healthy lung tissue that is at least 5 cm away from the tumor
- Case group: Before surgery, a breathing test confirmed you have COPD (a lung condition where airflow is limited, shown by a specific breathing test result)
- Control group: Your breathing test results before surgery are normal and you have no history of COPD
- You are able to understand and sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have been diagnosed with certain other lung conditions, such as scarring of the lung tissue (interstitial lung disease, pulmonary fibrosis, or lung scarring caused by dust exposure or tuberculosis)
- You currently have an active lung infection, such as bacterial pneumonia, a fungal infection, or active tuberculosis
- You have already received chemotherapy or radiotherapy before surgery, which could affect the lung tissue being studied
- You have a serious immune system deficiency, or you have been taking high-dose steroid medication (or similar immune-suppressing drugs) for more than 4 weeks
- You have another serious illness, such as severe heart failure or advanced kidney disease, that could affect your ability to take part or your life expectancy
- You are pregnant or breastfeeding
- You are unwilling to sign the consent form, or the researcher believes it would not be appropriate for you to join the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 18359181031
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clarify the relationship between airway mucus embolism and secondary pulmonary fibrosis in COPD patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.